Changes in peripheral blood CD5 (Bla) B‐cell populations and autoantibodies following blood transfusion
- 1 March 1995
- journal article
- Published by Wiley in Transfusion
- Vol. 35 (3) , 189-198
- https://doi.org/10.1046/j.1537-2995.1995.35395184273.x
Abstract
BACKGROUND: CD5 B cells and the natural autoantibodies they produce play a role in antigen presentation, tolerance induction, and maintenance of an idiotypic immune network. The effects of transfusion on autoantibodies and peripheral blood CD5 B cells were studied. STUDY DESIGN AND METHODS: Eight previously transfused patients with sickle cell anemia and five patients who underwent orthopedic surgical procedures with transfusion were enrolled in the study. Patients in both groups received 1 to 2 units of allogeneic packed red cells. Ten untransfused healthy adults and five patients who underwent orthopedic surgery without transfusion were enrolled as controls. Peripheral blood CD5 B cells, serum levels of IgM, antinuclear antibodies, rheumatoid factor, and anticardiolipin IgM were quantitated either at the beginning of the study (baseline sample), before transfusion, or before surgery and either at 1‐, 2‐, 4‐, 6‐, and 8‐week intervals after transfusion, after surgery, or after the baseline sample was obtained. RESULTS: IgM levels and the absolute number of B cells that coexpressed CD5 rose to twice pretransfusion levels in six of eight transfused sickle cell anemia patients and in four of five transfused orthopedic surgery patients. No comparable increases in CD5 B cells were noted in untransfused controls. Preexisting rheumatoid factor and antinuclear antibody levels increased in four of five transfused orthopedic surgery patients. One sickle cell anemia patient developed anti‐Fya despite receiving Fya‐negative blood. Increasing titers of anti‐Fya paralleled the increases in IgM and CD5 B cells after transfusion. One patient who developed a positive direct antiglobulin test after transfusion had large increases in serum anticardiolipin IgM. Anticardiolipin IgM was subsequently eluted from direct antiglobulin test‐positive red cells obtained after transfusion. Antibodies with anti‐Fya‐like activity and anticardiolipin IgM were produced in vitro by CD5 B cells and not by conventional CD5‐negative B cells. CONCLUSION: An association was found between transfusion‐induced increases in CD5 B cells and increased autoantibody production. These data may have implications for immunologic intervention to prevent the induction of red cell antibodies and other changes in the immune system caused by exposure to foreign antigens via blood transfusion.Keywords
This publication has 32 references indexed in Scilit:
- Lack of clinical significance of “enzyme‐only” red cell alloantibodiesTransfusion, 1993
- Immunochemical characterization of interactions between circulating autologous immunoglobulin G and normal human erythrocyte membrane proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Natural autoantibodies might prevent autoimmune diseaseImmunology Today, 1986
- The incidence of development of irregular red cell antibodies in patients with sickle cell anemiaTransfusion, 1986
- In vivo suppression of perinatal multispecific B cells results in a distortion of the adult B cell repertoireEuropean Journal of Immunology, 1986
- Functional characterization of monoclonal auto‐antiidiotype antibodies isolated from the early B cell repertoire of BALB/c miceEuropean Journal of Immunology, 1986
- SELECTION OF AUTOANTIBODIESThe Lancet, 1984
- Blood transfusion-induced suppression of cellular immunity in manHuman Immunology, 1980
- THE PRODUCTION OF ERYTHROCYTE AUTOANTIBODIES IN CHIMPANZEESThe Journal of Experimental Medicine, 1965